Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Dec;17(2):121-5.
doi: 10.1007/BF01966579.

Histamine H1- and H2-receptor involvement in eosinophil infiltration and the microvascular changes associated with cutaneous anaphylaxis

Histamine H1- and H2-receptor involvement in eosinophil infiltration and the microvascular changes associated with cutaneous anaphylaxis

D F Woodward et al. Agents Actions. 1985 Dec.

Abstract

Several substances alter eosinophil motility, but the relative importance of these putative mediators in immediate hypersensitivity remains unclear. The present study has re-investigated the role of histamine in type I allergic eosinophil infiltration, and the temporally associated microvascular events, by examining the effect of H1- and H2-receptor antagonist pretreatment. A combination of cimetidine and pyrilamine significantly reduced eosinophil accumulation, whereas neither antagonist alone was effective. Similarly, cutaneous hyperemia, measured indirectly as ear surface temperature, was reduced only by the cimetidine-pyrilamine combination. Pyrilamine partially attenuated the increase in microvascular permeability, but the addition of cimetidine provided no further reduction. It appears that histamine participates significantly in mediating both the microvascular changes and the eosinophil infiltration evoked by cutaneous anaphylaxis. The histaminergic component of increased microvascular permeability appears to be an H1-receptor mediated phenomenon. However, blockade of both H1- and H2-receptor subtypes is required to inhibit the hyperemia and eosinophil infiltration responses.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Int Pharmacodyn Ther. 1982 Jun;257(2):295-306 - PubMed
    1. J Allergy. 1964 Jan-Feb;35:77-85 - PubMed
    1. Eur J Pharmacol. 1982 Jan 22;77(2-3):103-12 - PubMed
    1. Nature. 1972 Apr 21;236(5347):385-90 - PubMed
    1. J Immunol. 1977 Jan;118(1):137-45 - PubMed

MeSH terms